Feedback / Questions
CIT-013 - Citryll
https://www.globenewswire.com/news-release/2024/07/31/2921572/0/en/CITRYLL-COMPLETES-PATIENT-DOSING-IN-THE-REPEAT-DOSE-STAGE-OF-THE-PHASE-1-TRIAL-FOR-THE-NOVEL-ANTI-INFLAMMATORY-CANDIDATE-CIT-013.html
Jul 31, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next